Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...

The XRP price may be at a significant risk of a big crash this year even as it faces major catalysts in the coming months.

Roche's drug portfolio shows promise, but mixed indicators reveal uncertainties. Check out the risks, opportunities, and ...

Launched in 2016, Solugen aims to offer a competitive alternative to the roughly $600 billion petrochemical industry, which ...

On today's Catalysts, hosts Seana Smith and Madison Mills cover key market updates alongside commentary from Wall Street ...

As soon as President Donald Trump was elected last year, the immediate expectation was that big things were coming for crypto ...

Vice President Kashim Shettima, has said that President Bola Tinubu was dedication to the health and survival of Nigerian enterprises. A statement on Tuesday in Abuja, by the spokesperson of the Vice ...

CAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today reported fourth ...

Crystal Amber (CRS:121.5p), the best-performing UK small-cap closed-end fund over the past 12 months has released an ...

Short-term market suppressions may be holding BTC back, but long-term trends suggest continued growth as regulatory clarity ...

In the fresh funding round, Venture Catalysts and angel investors including Nitin Gupta (Uni Cards and PayU,) Maninder Gulati ...